⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27264989 | 0.87 | TDP1 (0.41) | — | |
| SCHEMBL8451148 | 0.81 | TDP1 (0.39) | — | |
| SCHEMBL27761184 | 0.79 | TDP1 (0.37) | — | |
| SCHEMBL30963050 | 0.78 | FFAR3 (0.35) | — | |
| SCHEMBL7717708 | 0.78 | BLM (0.37) | — | |
| SCHEMBL13103900 | 0.76 | LMNA (0.44) | — | |
| SCHEMBL13103928 | 0.76 | ALDH1A1 (0.38) | — | |
| SCHEMBL7720623 | 0.76 | TSHR (0.33) | — | |
| SCHEMBL2058387 | 0.73 | — | — | |
| SCHEMBL3338460 | 0.72 | FFAR3 (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8114599-B2 | Using multiplexed single-base extension assays comprising monodisperse uncharged polyamides conjugated to preferential nucleotide sequences for genotyping samples | NORTHWESTERN UNIVERSITY (US) | 2012-02-14 | — | — | US | claimed |
| EP-1868739-A2 | METHOD FOR PRODUCING, AND A SUBSTRATE WITH, A SURFACE WITH SPECIFIC CHARACTERISTICS | UNIVERSITY OF DURHAM (GB) | 2007-12-26 | — | — | EP | claimed |
| WO-2006109055-A2 | METHOD FOR COATING A SUBSTRATE TO GIVE PROTEIN RESISTANCE AND COATED SUBSTRATE | UNIVERSITY OF DURHAM (GB) | 2006-10-19 | — | — | WO | claimed |
| US-20250320253-A1 | TRANSMEMBRANE PEPTIDIC ANTAGONISTS OF PLEXIN-A1 AND THEIR THERAPEUTIC USES | UNIV STRASBOURG (FR) | 2025-10-16 | — | — | US | disclosed |
| EP-4628592-A1 | PEPTIDE PRODUCTION METHOD COMPRISING STEP FOR TRANSLATING AMINO ACID HAVING OXYGEN ATOM AT SPECIFIC POSITION | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2025-10-08 | — | — | EP | disclosed |
| EP-4398924-A1 | TRANSMEMBRANE PEPTIDIC ANTAGONISTS OF PLEXIN-A1 AND THEIR THERAPEUTIC USES | Université de Strasbourg (FR) | 2024-07-17 | — | — | EP | disclosed |
| WO-2024128195-A1 | PEPTIDE PRODUCTION METHOD COMPRISING STEP FOR TRANSLATING AMINO ACID HAVING OXYGEN ATOM AT SPECIFIC POSITION | 中外製薬株式会社 | 2024-06-20 | — | — | WO | disclosed |
| CN-118201628-A | Transmembrane peptide antagonists of plexin A1 and therapeutic uses thereof | 斯特拉斯堡大学 | 2024-06-14 | — | — | CN | disclosed |
| EP-3383888-B9 | NEW PEPTIDES HAVING ANTIMICROBIAL ACTIVITY AND NEW ENZYME CAPABLE OF CONVERTING L-CONFIGURED RESIDUE IN D-CONFIGURED AMINO ACID IN A PEPTIDE | INSTITUT NATIONAL DE RECH POUR LAGRICULTURE LALIMENTATION ET LENVIRONNEMENT (FR) | 2023-10-04 | — | — | EP | disclosed |
| EP-3383888-B1 | NEW PEPTIDES HAVING ANTIMICROBIAL ACTIVITY AND NEW ENZYME CAPABLE OF CONVERTING L-CONFIGURED RESIDUE IN D-CONFIGURED AMINO ACID IN A PEPTIDE | INSTITUT NATIONAL DE RECH POUR LAGRICULTURE LALIMENTATION ET LENVIRONNEMENT (FR) | 2023-06-07 | — | — | EP | disclosed |
| EP-4149509-A1 | SURFACTANT PROTEIN C MIMICS DISPLAYING PATHOGEN- OR ALLERGEN-BINDING MOIETIES | Barron, Annelise E. (US) | 2023-03-22 | — | — | EP | disclosed |
| WO-2023036842-A1 | TRANSMEMBRANE PEPTIDIC ANTAGONISTS OF PLEXIN-A1 AND THEIR THERAPEUTIC USES | UNIVERSITE DE STRASBOURG (FR) | 2023-03-16 | — | — | WO | disclosed |
| EP-3996733-A1 | A PEPTOID-PEPTIDE HYBRID, NMEG-ACGRP, AND ITS USE IN CARDIOVASCULAR DISEASES | University of South Carolina (US) | 2022-05-18 | — | — | EP | disclosed |
| WO-2021231343-A1 | SURFACTANT PROTEIN C MIMICS DISPLAYING PATHOGEN- OR ALLERGEN-BINDING MOIETIES | BARRON ANNELISE E (US) | 2021-11-18 | — | — | WO | disclosed |
| WO-2021022117-A1 | A PEPTOID-PEPTIDE HYBRID, NMEG-ACGRP, AND ITS USE IN CARDIOVASCULAR DISEASES | UNIVERSITY OF SOUTH CAROLINA (US) | 2021-02-04 | — | — | WO | disclosed |
| CN-108431033-A | The treatment of bone uptake illness | 泰莱托恩基金会 | 2018-08-21 | — | — | CN | disclosed |
| CN-107109452-A | The method and apparatus of nucleic acid | 分子组装公司 | 2017-08-29 | — | — | CN | disclosed |
| EP-1868739-A2 | METHOD FOR PRODUCING, AND A SUBSTRATE WITH, A SURFACE WITH SPECIFIC CHARACTERISTICS | UNIVERSITY OF DURHAM (GB) | 2007-12-26 | — | — | EP | disclosed |
| WO-2006109055-A2 | METHOD FOR COATING A SUBSTRATE TO GIVE PROTEIN RESISTANCE AND COATED SUBSTRATE | UNIVERSITY OF DURHAM (GB) | 2006-10-19 | — | — | WO | disclosed |